Menu

Podcasts

Latest podcasts

September 2024

Exploring Second-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia (CLL)
Dr. Adam Kittai (Icahn School of Medicine, Mount Sinai, New York)
January 2024
PODCASTS 

Dr Deeren discusses the latest update in the management of patients with Paroxysmal Nocturnal Hemoglobinuria including the place of the new long acting C5 inhibitor ravulizumab in the treatment algorithm
Dr. Dries Deeren (AZ Delta, Roeselare)
September 2023

Prof. Paolo Ghia discusses the results of a matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia
Prof. Paolo Ghia (Università Vita Salute San Raffaele, Italy)
All podcasts
Top